## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

PARABOLIC warning: MRS_20 at 11.4% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($154.82)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 4
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. AQR Capital Management LLC Acquires 40,714 Shares of Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20251213T085225 | Somewhat-Bearish | Relevance: 100%
- AQR Capital Management LLC has increased its stake in Molina Healthcare, Inc. by 4.6%, purchasing an additional 40,714 shares to now own 925,672 shares valued at $273.1 million. Despite this increased institutional interest, Molina Healthcare missed its quarterly EPS expectations, and several analysts have recently lowered price targets and ratings, leading to an average "Hold" consensus. The company, which provides managed healthcare services, has a market capitalization of $9.13 billion and a P/E ratio of 10.43.

**2. Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Connect**
- Source: WPRI.com | 20251214T160823 | Somewhat-Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) on behalf of investors who purchased securities before February 5, 2025, and still hold them. The investigation focuses on whether Molina, its officers, and/or directors engaged in corporate wrongdoing. The firm encourages affected stockholders to contact them to assist with the investigation.

**3. Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Connect**
- Source: MyStateline | 20251214T160820 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) for corporate wrongdoing involving its officers and/or directors. The firm encourages stockholders who purchased Molina securities before February 5, 2025, and still hold them, to contact them to assist with the investigation. This investigation operates on a contingency fee basis with no direct cost to the stockholders.

**4. State Street Corp Has $732.83 Million Stake in Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20251213T130838 | Somewhat-Bearish | Relevance: 100%
- State Street Corp reduced its stake in Molina Healthcare by 1.2% in Q2, now holding 2,459,996 shares valued at $732.83 million. Other institutional investors like Price T. Rowe Associates Inc. MD and Norges Bank have significantly adjusted their positions in MOH. Molina Healthcare also reported missing Q2 EPS expectations but saw an 11% revenue increase and provided FY2025 guidance.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Valuation risk: PEG 2.6x with declining EPS estimates leaves no margin for error.
2. Elevated short interest (11.4%): bears positioning against stock.
3. Long-term trend broken: trading 28.6% below SMA200.
4. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Momentum building: MRS_20 improving +5.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.62 signals overvaluation risk, limited margin of safety. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.0B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.62 |
| Forward P/E | 12.3 |
| Current P/E | 12.0 |
| YoY Growth | -2.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 6.1% to 11.4% (+5.4% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (11.4% > 10.0%), caution on chasing. MRS_5 at 3.2% confirms short-term momentum alignment. AM_20 at 11.1% shows strong absolute momentum above own 20MA. Outperforming sector by 10.0pp, stock-specific strength. Below SMA200 (0.71x), long-term trend not supportive. MACD histogram positive (3.52), confirming momentum. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 11.42% (CS: 97) | Strong |
| RSI_14 | 64.3 | Neutral |
| MACD Histogram | 3.52 | Bullish |
| vs SMA20 | 1.111x | Above |
| vs SMA50 | 1.026x | Above |
| vs SMA200 | 0.714x | Below |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $166.50
- **Stop Loss:** $154.82 (7.0% risk)
- **Target:** $178.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 102
- **Position Value:** $16,983.00
- **Portfolio %:** 16.98%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*